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Abstract 
South Australia is a biodiversity hotspot of marine sponges and macroalgae. This 
study aimed to evaluate the potential neuroprotective activity of extracts from these 
two marine sources by reducing the toxicity of human amyloid beta Aβ1 -42 in a cell 
model assay using PC-12 cells. A total of 92 extracts (43, 13, 16, and 20 extracts from 
sponge of 8 orders and 17 families, green algae of 3 orders and 4 families, brown 
algae of 6 orders and 8 families, and red algae of 5 orders and 10 families, 
respectively) were initially screened at three different concentrations (0.25, 2.5 and 25 
µg/ml) to evaluate their toxicity using the MTT assay. About half of these extracts 
(26, 6, 5, and 10 extracts from sponge, green algae, brown algae, and red algae, 
respectively) showed some cytotoxicity, and were hence excluded from further 
assays. The rest of extracts (45 extracts in total) at 0.25 and 25 µg/ml were 
subsequently screened in a neuroprotection assay against Aβ1-42 cytotoxicity. A cell 
viability reduction of 30% was observed in the MTT assay when the cells were treated 
with 1µM Aβ1 -42. 29 extracts (13, 4, 7, and 5 extracts from sponge, green algae, 
brown algae, and red algae, respectively) reduced the toxicity induced by Aβ1-42 
(P<0.05), indicating neuroprotective activity. These results demonstrate that marine 














neuroprotective compounds against the hallmark neurotoxic protein in Alzheimer’s 
disease (AD). 
 
Keywords: Marine sponges; macroalgae; neuroprotective activity; amyloid beta; 
South Australia 
1- Introduction: 
Alzheimer’s disease (AD) is a neurodegenerative disease responsible for 60-80% of 
dementia cases (Alzheimer'sAssociation, 2014). Current treatment strategies for AD 
mostly target acetylcholinesterase and the N-methyl-D-aspartate (NMDA) receptor. 
However, these treatments can only mitigate some of the cognitive and memory loss 
symptoms and are not considered disease-modifying. Hence, the development of new 
treatments for AD are required (Scarpini et al., 2003).  
One of the main hallmarks of AD is the presence of amyloid beta (Aβ) protein that 
forms plaques in the brain. Aβ1-40 and Aβ1-42 are major forms generated from the 
cleavage of amyloid precursor protein (APP) by β-secretase and γ-secretase (Hussain 
et al., 1999). It is suggested that the aggregation and diminished clearance are 
pathogenic factors of AD (Hardy and Selkoe, 2002). Animal studies demonstrate that 
amyloid plaques are correlated with memory defects (Hsiao et al., 1996). For that 
reason, targeting Aβ may be considered an effective approach in the treatment of AD 
(Hardy and Selkoe, 2002).  
 
Marine sponges, one of the oldest multicellular animals on the planet (Hentschel et 
al., 2002),  are a rich source of natural compounds contributing more than 30% of all 
compounds discovered from marine organisms (Mehbub et al., 2014). These 
compounds possess a spectra of biological activities including anti-viral, anti-














neuroprotective compounds from marine sponges ascribed a variety of mechanisms to 
their neuroprotection, including glutamate and serotoninergic receptor activity, kinase 
inhibition, neuritogenic and anti-oxidant activity (Alghazwi et al., 2016a). 
Interestingly, seven out of 90 neuroprotective compounds were reported as sourced 
from Australian species.  
 
Macroalgae (or seaweeds) have been known for their uses in food and as potential 
drug sources. Macroalgae can be classified based on the pigment colours into 
different phyla such as Chlorophyta, Ochrophyta (class Phaeophyceae), and 
Rhodophyta which are commonly named as the green, brown and red algae, 
respectively (Lobban and Harrison, 1994, Guiry, 2012). Macroalgae present a range 
of biological activities such as anti-viral, anti-bacterial, antioxidant, anti-cancer and 
neuroprotective activity (Wang et al., 2008, Lima-Filho et al., 2002, Kang et al., 2003, 
Kang et al., 2004, Aisa et al., 2005, Pangestuti and Kim, 2011). A recent review 
reported  a total of 99 compounds isolated from macroalgae demonstrating 
neuroprotective activities (Alghazwi et al., 2016b). The mechanisms ascribed to these 
effects included inhibiting Aβ aggregation and acetylcholinesterase inhibition, 
decreasing oxidative stress and kinase activity, enhancing neurite outgrowth, anti-
inflammatory activity and protecting dopaminergic neurons.    
 
South Australian waters have more than 1000 different species of sponges that belong 
to 200 genera (Bergquist and Skinner, 1982). South Australia hosts one of the highest 
diversity of macroalgae, as it is home to over 1200 species with  62% of them  as 
endemic (Phillips, 2001, Womersley, 1996). Few studies have reported 














with only seven neuroprotective compounds from sponges. Esmodil was shown to 
inhibit acetylcholinesterase (Capon et al., 2004), while debromohymenialdisine 
inhibited CDK5/p25, CK1, and GSK-3β (Zhang et al., 2012c). Four compounds 
(Lamellarins O1, Ianthellidone F, lamellarins O2 and O) were shown to inhibit β-site 
amyloid precursor protein cleaving enzyme (BACE) (Zhang et al., 2012a), in addition 
to Dictyodendrin J (Zhang et al., 2012b). Moreover, only 3 compounds isolated from 
macroalgae collected in Australia were shown to have demonstrated neuroprotective 
activity. Spiralisone A, spiralisone B, and chromone 6 showed inhibition of 
CDK5/p25, CK1δ and GSK3β kinases (Zhang et al., 2012d). Therefore the present 
study was conducted to evaluate the potential of South Australia marine sponge and 
macroalgae extracts as a source of neuroprotective compounds, with a focus on 
reducing the cytotoxicity of Aβ in neuronal PC-12 cells.  
2- Materials and Methods  
 
2.1- Samples collection 
The Australian Institute of Marine Science (AIMS) provided all the samples used in 
this study. These samples were collected by hand whilst scuba diving or from 
shallows at low tide. They were frozen after a representative taxonomy sample was 
taken. All samples were collected in South Australia. The details of collections sites 
can be found in the Table 1.  
The taxonomy information was provided by AIMS. Phylogenetic trees of these 
samples were conducted according to their class, order, family, genus, and species 
with a guide from http://www.algaebase.org/ (for algae samples) (Guiry and Guiry, 
2014) and http://www.marinespecies.org/porifera/ (for sponge samples) (Van Soest et 















The marine samples were divided in four different categories based on their class for 
sponges (Demospongiae) or phyla for macroalgae (Chlorophyta, Ochrophyta, and 
Rhodophyceae). For each category a separate phylogenetic distribution was 
constructed to distribute the class into order, family, genus, and species, respectively.  
 
All the sponge samples were from Demospongiae class with a broad distribution of 8 
orders and 17 families (Figure 1). In Chlorophyta, there were 3 orders and 4 families 
(Figure 2). In Phaeophyceae, there were 6 orders and 8 families (Figure 3). In 
Rhodophyceae, there were 5 orders and 10 families (Figure 4). 
 
Figure 1: Phylogenetic distribution of sponge species among order, family, and 














Figure 2: Phylogenetic distribution of green algae species among order, family, 















Figure 3: Phylogenetic distribution of brown algae species among order, family, 















Figure 4: Phylogenetic distribution of red algae species among order, family, and 

































Table1: The location sites of the different algal and sponges species collected in South 
Australia 
Sample code Location Sample code Location 
C9, C12 
R17 
Third way from Cape Jaffa to 






Nore Creina Beach near Robe; 
South-East S.A. 
D15, D19, D26 
P2 
R4, R5 
Marion Reef off Edithburgh; 






















Horseshoe Reef-0.65 miles; 355 
degrees to Margaret Brock Light; 
near Kingston; S.A. 
 
C6 
D2, D6, D11, 
D32, D35, D36 
 
American River; Green side of 
channel west of Strawbridge Point; 
Kangaroo Island; S.A 
 
C5, C13 
Coobowie Bay; Southern. Yorke 
Peninsula; S.A. 
 
D1, D17, D29, 
D33, D42 
 
Smith Bay; West of Cape D'estaing; 





Margaret Brock Reef just near 
lighthouse (ne); near Kingston; S.A. 
 




Between Knob Point and Cape 




Cape Thomas; half way between 
Kingston and Robe; S.A. 
 
D10, D21, D37 
P7 
R16 
Point Ellen, Vivonne Bay; 








Cape D'estaing; North of Reef; 
Emu Bay; Kangaroo Island; S.A. 
P13 
R2, R3 
Old Jetty Piles; Kingston Jetty; 
Kingston; SE; S.A. 
D18, D20, D22 
 
Smith Point; West of D'estaing; 
Kangaroo Island; S.A. 
 
D40 
P5, P15, P16 
R10, R14, R15, 
R20 
Godfrey Island; between Kingston 
and Robe; STHN. S.A. 
D30, D34, D43 
West of Cape D'estaing; Emu Bay; 









Pandalowie Bay; South of lookouts; 
STHN Yorke Peninsula; S.A. 
 
D14, D28, D39 
 
1KM off Margaret Brock 





Edithburgh Jetty, North of Jetty; 




Horseshoe Reef 3km wnw of 
Margaret Brock Lighthouse; Cape 




Edge of Marine Reserve - Pelican 





Outside Port Mcdonnell - Deep 
Creek (old dairy factory creek); 


























2.2- Extract preparation 
A small subsample was removed and placed in a glass vial. The sub-samples were 
freeze dried. After the samples were dried they were steeped in either ethanol or 
methanol then stored at -20°C. The extracts were frequently refreshed with either 
ethanol or methanol. 
2.3- Sample Preparation for the Queensland Compound 
Library (QCL) /Compounds Australia 
The extract collection was removed from the freezer one day prior to use and 
refreshed with methanol to the top of the vial and well mixed. A 975 µL aliquot was 
removed from the extract vial and pipetted into a 96 deep well Macrotitre plate. The 
solvent was removed under vacuum in a Savant Drier. An adhesive foil lid was placed 
on the samples and they were stored at -20°C until delivered to QCL/Compounds 
Australia on dry ice. QCL/Compounds Australia reconstituted the samples in DMSO 
to a final concentration of 5 mg/mL. 
2.4- Preparation of sponge and macroalgae extracts 
samples for biological assays 
Samples received from QCL were prepared in three different concentrations (0.05, 0.5 
and 5 mg/ml) by dissolving the AIMS sample in DMSO. All samples were kept cold 
in the freezer at -20 °C.  
2.5- Reagents 
  
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 97.5%) was 














buffered saline (PBS) at 5 mg/ml, then filtered through 0.22 μm sterile filter 
(Sartorius Stedim Biotech, France) prior to use and then was stored in the freezer at -
20°C. RPMI-1640 medium was purchased from Sigma-Aldrich (USA). Foetal bovine 
serum (FBS) was purchased from Bovogen Biologicals (East Keilor, VIC, Australia). 
Penicillin/streptomycin and 10× trypsin EDTA were obtained from Thermo Fisher 
Scientific (Scoresby, VIC, Australia). Human amyloid-β1–42 protein (Aβ1–42) was 
obtained from Mimotopes (Melbourne, VIC, Australia). Pierce™ LDH cytotoxicity 
assay kit (Catalogue number: 88953) was purchased from Thermo Fisher Scientific 
(USA). 
2.6- Cell lines and cell culture 
 
Ordway PC-12 cells were grown in RPMI-1640 media with 10% Foetal Bovine 
Serum and 50 μg/ml penicillin and streptomycin. These cells were maintained in an 
incubator at 37 °C temperature and 5% CO2.  
PC-12 cells were treated with different concentrations of marine extract samples 
(0.25, 2.5, and 25 µg/mL) for 48 hours. The control group was treated with 1×PBS for 
the same amount of time. In addition, a solvent control contains 0.5% of DMSO in 
media was used to make sure that DMSO was not causing cell death. All marine 
extract samples were dissolved in DMSO with the final concentration less than 0.5% 
(v/v). All experiments were carried out in triplicate. 
2.7- Cell viability assessment using MTT assay 
The MTT assay is widely used to measure mitochondrial activity as an indicator of 
cell viability. PC-12 cells were seeded at 2×10
4
 cells per well in 100 µl media in 96-
well plates. The plates were kept in the incubator to attach the cells overnight. On the 
second day, the marine extracts were applied to the cells at final concentrations of 














On the fourth day, the plate was taken out and the media removed before adding 100 
μl of MTT solution at a concentration of 0.5 mg/ml in 1×PBS. The plate was kept in 
aluminium foil and incubated for further 2 hours at 37 °C. Then, the MTT mixture 
was removed from the wells and 100μl of DMSO (Sigma Aldrich) was added to each 
well to dissolve formazan into a coloured product that can be measured by a plate 
reader. The plate was read in a microplate reader (μQuant) at 570 nm. The 
cytotoxicity of marine extracts calculated by comparing the absorbance to cells which 
were treated with PBS (these cells were considered as 100% cell viability).  
2.8- Preparing Aβ for treating cells 
DMSO at 1% was used to dissolve non-fibrillar Aβ1–42 to yield a protein concentration 
of 3.8 mM. After that, sterile PBS was added to prepare a final concentration of 100 
μM. Amyloid was then dispensed into aliquots and immediately frozen at −70 °C until 
required. 
2.9- Neuroprotection study 
To assess the neuroprotective activity, only extracts that showed more than 90% cell 
viability at three different concentration tested earlier were selected for this assay, as 
treating cells with 1 µM Aβ1–42 causing 20-30% of cell death. 
PC-12 cells were used to evaluate the potential neuroprotective effects of the extracts 
using the MTT assay. Cells were plated at 2×10
4
 cells per well in RPMI-1640 and 
10% fetal bovine serum. Cells were then treated with the extracts at two different 
concentrations (0.25 and 25 μg/ml), either alone or 15 minutes prior to the addition of 
1 μM Aβ1–42. All cells were incubated for 48 hours. MTT was then added (0.5 mg/ml 
for 2 hours) and cells were lysed with DMSO. Spectrophotometric absorbance at 570 















2.10- LDH assay 
The assay was conducted according to the manufacturer’s guideline. After treating 
cells with extracts for 48 hours, 50 µl of media was transferred to a new plate and 
mixed with 50 µl of substrate and incubated in dark at room temperature for 30 
minutes. After that, 50 µl of stop solution was added and the plate was read in a plate 
reader at 490 nm and 680 nm. The % of cytotoxicity was calculated using this 
formula: 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦% =
100 − [(𝐸𝑥𝑡𝑟𝑎𝑐𝑡 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝐿𝐷𝐻 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 –  𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝐿𝐷𝐻 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦) ÷
(𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝐿𝐷𝐻 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 –  𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝐿𝐷𝐻 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦)  × 100] 
Where spontaneous LDH activity was the media control (untreated wells), while 
maximum LDH activity was the lysis buffer treatment that was added to the cells for 
45 minutes.  
2.11- Statistical analysis  
 
All results were based on at least three independent experiments (n = 3). The effects 
of marine extracts on the viability of PC12 cells were analysed using one way 
ANOVA, followed by Tukey’s honestly significant difference (HSD) post-hoc test for 
equal and unequal variances as appropriate. All data were analysed using SPSS 
software (Version 22). Differences were considered statistically significant when p-
values were less than 0.05. Bonferroni correction was used to highlight the significant 
neuroprotective extracts from each sample group (P<0.0029 for sponge), (P<0.007 for 


















3.1 Cytotoxicity of extracts of marine sponges and macroalgae 
from South Australia  
The cytotoxicity of 93 marine extract samples were screened against PC-12 cells 
using the MTT assay at three different extract concentrations (0.25, 2.5, and 25 
µg/ml). The results were analysed to determine which extracts did not kill more than 
10% of cells in any concentration.  Tables 2-5 shows the cytotoxicity screening results 
after treating with marine sponge extracts, green algae, brown algae and red algae, 
respectively. Twenty six out of 43 sponge extracts, six out of 13 green algae extracts, 
five out of 16 brown algae extracts, and ten out of 20 red algae extracts showed 
cytotoxicity, with cell viability being less than 90% at one of the three concentrations 
tested (Tables 2-5). Overall, there was nearly 50% of all extracts exhibited 
cytotoxicity at one of the three concentrations tested, with marine sponges the most 
toxic (60.5% of extracts) and brown algae the least toxic extracts (only 31.25% of 
extracts) (Table 4). Based on the taxonomic evaluation of sponges’ species (Figure 1), 
all the species of Ircinia genus were toxic with the exception of D8. Two third of the 
species from Dictyoceratida and Haplosclerida orders were toxic. Six extracts out of 
13 did not show cytotoxicity in Poecilosclerida order, with all of the extracts being 
cytotoxic in Chondropsidae, Coelosphaeridae, and Desmacididae families. In green 
algae (Figure 2), all the extracts from Codiaceae family were safe to PC-12 cells. On 
the other hand, Caulerpaceae family was the most toxic family, as all of the species 
showed cell viability below 90% with the exception of C3. The taxonomic 
distribution of brown algae (Figure 3) showed that all the species of Sporochnales and 
Sphacelariales were not toxic to the cells, while almost one third of Fucales order 














(Figure 4) showed that both Gigartinales (with the exception of R12) and Gracilariales 
orders were cytotoxic, while all the species of Ceramiales order were not cytotoxic to 
PC-12 cells with the exception of R5.  
 
Table 2: Summary of sponge extract toxicity against neuronal PC-12 cells at three 
different extract concentrations (n=3) (* p <0.05, ** p <0.01, and ***p <0.005 versus 
control PBS) 
Sample No Cell viability at different extract 
concentrations (%) 
Sample No Cell viability at different extract 
concentrations (%) 
0.25 µg/mL 2.5 µg/mL 25 µg/mL 0.25 µg/mL 2.5 µg/mL 25 µg/mL 
D1 78.7 ± 1.2 
*** 
78.7 ± 3.5 
***
 75.2 ± 2.6 
***
 D23 89.2 ± 1.7 
*
 96.5 ± 2.4 87.8 ± 2.1 
*
 
D2 99.2 ± 2.1 96.6 ± 1.4 90.5 ± 5.1 D24 93.1 ± 3.5 92 ± 2.1 86.2 ± 2.6 
*
 
D3 90.9 ± 3.6 90.7 ± 2.5 94.6 ± 1.1 D25 95.6 ± 1.3 93.3 ± 0.5 84.7 ± 2.9
***
 
D4 92 ± 3.6 76.8 ± 9 
*
 84 ± 1.2  D26 81.1 ± 6.3 * 87.3 ± 2.2  80.9 ± 1.7 * 
D5 99.8 ± 3.6 92.4 ± 1.6 88.1 ± 3.5 D27 79.5 ± 5.2 
**
 79.9 ± 1.8
 **
 80.2 ± 0.3 
**
 
D6 81.9 ± 2.3 
**
 76 ± 3.3 
***
 76.8 ± 2.6 
***
 D28 88.5 ± 2.3 
*
 87.4 ± 2.6
*
 89.9 ± 0.5
*
 
D7 93.3 ± 6.9 95.1 ± 1.5 77.3 ± 3.6 
*
 D29 80.7 ± 1.1 
**
 78.9 ± 4.9
***
 82.8 ± 1.2 
*
 
D8 90.3 ± 2.6 90.2 ± 3.3 93 ± 4.4 D30 90.4 ± 0.4 90.9 ± 3.5 90.5 ± 2.3 
D9 75.1 ± 1.7 
***
 74.6 ± 1.1 
***
 68.8  ± 2 
***
 D31 97.3 ± 1.6 99..2 ± 0.2 96.1 ± 1.6 
D10 95.7 ± 0.9 100.9 ± 3.1 94.4 ± 2.6 D32 96 ± 5.3 93.3 ± 1.4 82.4 ± 6.6 
D11 96.4 ± 1.7 96.1 ± 0.5 94.2 ± 0.8 D33 95.7 ± 2.6 92.9 ± 2.5 91.3 ± 0.9  
D12 84.6 ± 3.7 
*
 84.6 ± 2.2 
*
 78.5 ± 1.6 
***














D13 92.5 ± 3.6  85.8 ± 2.4  87.4 ± 1.9  D35 98.5 ± 1.8 100.6 ± 2.9 91.7 ± 0.8 
*
 
D14 71.9± 8 
**
 74 ± 1.3 
*
 70.7 ± 1
**
 D36 93.2 ± 3.9 90.3 ± 1.9  93.2 ± 0.3 
D15 83.5 ± 1.9 
***
 82.9 ± 1.4 
***
 86.7 ± 1.3 
**
 D37 88.1 ± 0.9 
*
 89.1 ± 1.4 
*
 87.9 ± 2.8 
*
 
D16 95.4 ± 2.1 92.5 ± 4.8 94.8 ± 3.6 D38 75.9 ±1.5 
*
 71.6± 5.4 
**
 74.6 ± 0.9 
**
 
D17 92.9 ± 1.3 95.7 ± 2.6 29.9 ± 1.3 
***
 D39 101.7 ± 2.2 100.6 ± 2.3 96.3 ± 0.7 
D18 99.4 ± 3.8 99.6 ± 2.8 39.4 ± 2.5 D40 105.8 ± 0.8 95.2 ± 2.8 95.4 ± 3.2 
D19 96.4 ± 2 90.8 ± 2.1 96.3 ± 2.7 D41 91.5 ± 1.8  87.4 ± 2.9 
*
 87.6 ± 1.1
* 
D20 80.2 ± 2.9 
***
 80.7 ± 2.6 
***
 80.3 ± 1.5 
***
 D42 96.9 ± 3.5 94.3 ± 3.2 102.2 ± 2.5 
D21 95.8 ± 4.8 96.5 ± 2.3 94.2 ± 2.5 D43 95.6 ± 1 100.1 ± 2.3 97.6 ± 0.2 
D22 84 ± 0.8 
***
 72.1 ± 3.3 
***
 7.7 ± 0.5 
***
     
 
Table 3: Summary of green algae extract toxicity against neuronal PC-12 cells at three 
different extract concentrations (n=3) (* p <0.05, ** p <0.01, and ***p <0.005 versus 
control PBS) 
Sample No Cell viability at different extract 
concentrations (%) 
Sample No Cell viability at different extract 
concentrations (%) 
0.25 µg/mL 2.5 µg/mL 25 µg/mL 0.25 µg/mL 2.5 µg/mL 25 µg/mL 
C1 83.9 ± 1.2 
**
 87.5 ± 2.1 
*
 80.4 ± 2.8 
***
 C8 94.9 ± 1.3 92.4 ± 2.9 92.2 ± 2.3 
C2 86.6 ± 4.8  82.5 ± 8.9 80.3 ± 5.5  C9 90  ± 2.7 91.9 ± 2.7 91.2 ± 2.2 
C3 101.2 ± 0.2 98.9 ± 2.1 100.6 ± 0.9 C10 90.3 ± 1.4  91.3 ± 2.1 90.4 ± 2.9 
C4 87.2 ± 1.3 
***
 87.4 ± 1.1 
***
 85.9 ± 1 
***














C5 80.9 ± 2.2 
***
 81.3 ± 2 
***
 78.3 ± 1.4 
***
 C12 99.9 ± 2.3 98.7 ± 0.6 91.1 ± 3.2 
C6 82.8 ± 2.9 
***
 79.6 ± 0.2 
***
 72.9 ± 1 
***
 C13 91.3 ± 3.1 88.5 ± 2.3  85.9 ± 2.2 
*
 
C7 101.9 ± 3.9 98.6 ± 4.6 98.7 ± 0.4     
 
Table 4: Summary of brown algae extract toxicity against neuronal PC-12 cells at 
three different extract concentrations (n=3) (* p <0.05, ** p <0.01, and ***p <0.005 
versus control PBS) 
Sample No Cell viability at different extract 
concentrations (%) 
Sample No Cell viability at different extract 
concentrations (%) 
0.25 µg/mL 2.5 µg/mL 25 µg/mL 0.25 µg/mL 2.5 µg/mL 25 µg/mL 
P1 88.9 ± 0.7  86.5 ± 4.8 84.2 ± 3.9 
*
 P9 95.7 ± 3.6 92.5 ± 2.7 90.4 ± 1.7  
P2 102.1 ± 0.6 104.2 ± 2 101.2 ± 1.8 P10 96.2 ± 0.8 91.9 ± 2.2 98.9 ± 2.1 
P3 92 ± 2.7 92.4 ± 2.3 92.1  ± 2.1 P11 88 ± 2.8 
*
 83.6 ± 0.5
***
 81.7 ± 2.1
***
 
P4 85.3 ± 2.9 
**
 89.4 ± 1.3 
*
 84.4 ± 1.6 
**
 P12 88.9 ± 3.2 91.8 ± 1.7 87.9 ± 2.1 
*
 
P5 97.3 ± 2 93.5 ± 3 92.1 ± 1.9 P13 97.7 ± 2.7 92.5 ± 2.6 98.1 ± 2.4 
P6 91.3 ± 1.9 94.2 ± 2.7 92.8 ± 3.7 P14 91.8 ± 0.9 
*
 90.4 ± 1.3 
*
 91.9 ± 1.3 
*
 
P7 97.4 ± 1.5 96.9 ± 1.1  108.1 ± 2.5 P15 98.9 ± 1.7 95.4 ± 2 92.8 ± 1.7 
P8 87.3 ± 1.5 
*
 87.9 ± 1.6 
*
 82.9 ± 2.1 
***
 P16 90.9 ± 0.8 
*



















Table 5: Summary of red algae extract toxicity against neuronal PC-12 cells at three 
different extract concentrations (n=3) (* p <0.05, ** p <0.01, and ***p <0.005 versus 
control PBS) 
Sample No Cell viability at different extract 
concentrations (%) 
Sample No Cell viability at different extract 
concentrations (%) 
0.25 µg/mL 2.5 µg/mL 25 µg/mL 0.25 µg/mL 2.5 µg/mL 25 µg/mL 
R1 94.4 ± 3.3 95.2 ± 2.7 97.9 ± 1.3  R11 93.6 ± 1.5 94.3 ± 2.7 90 ± 1.3 
*
 
R2 90.7 ± 0.3 
*
 90.3 ± 0.5 
*
 90.3± 1.3 
*
 R12 94.5 ± 0.5 92.6 ± 2.2 92.3 ± 0.7 
R3 94.9 ± 0.9 94.3 ± 1.6 97.5 ± 2.4 R13 87.4 ± 0.8
*
 84.9 ± 1.4 
**
 82.9 ± 2.9
***
 
R4 90.3 ± 5.9 100.6 ± 2.3 90.4 ± 1.3 R14 98.2 ± 1.4 98.7 ± 4.6 85.9 ± 2.8
*
 
R5 86.2 ± 0.6 
***
 87.7 ± 0.6 
**
 86.4 ± 2 
***
 R15 77.9 ± 0.7
***
 82.5 ± 1.6 
**
 83.5 ± 4.2 
**
 
R6 77.4 ± 0.5 
***
 78.9 ± 1.1 
***
 76.2 ± 0.9 
***
 R16 86.2 ± 0.6 
*
 87.8 ± 3.7 88.6 ± 3.2 
R7 91.7 ± 3.2 91.8 ± 1.3 96 ± 1.4 R17 89.6 ± 3.3 88.5 ± 1.5 
*
 88.9 ± 2.1 
R8 93.9 ± 1.4 96.5 ± 2.8 92.6 ± 3.3 R18 75.4 ± 0.5
***
 74.1 ± 0.4
***
 81 ± 1
***
 
R9 89.6 ± 1.1 
*
 85 ± 1.9 
***
 86.6 ± 1.4 
**
 R19 85.1 ± 2.2 
*
 85.9 ± 0.3 
*
 83.6 ± 3.3 
** 
R10 94.6 ± 2 93 ± 1.7 95.1 ± 2.7 R20 99 ± 2.9 97.6 ± 3.6 99.9 ± 5.6 
 
3.2 Neuroprotective activity of extracts of marine sponges and 
macroalgae from South Australia 
Only these extracts at any of these three concentrations showing cell viability of more 
than 90% were used in this assay. The sponge and macroalgae extracts were applied 














for 48 hours before assessing cell viability. Treating the cells with Aβ1-42 alone 
resulted in 25-35% reduction in cell viability (Figure 5-8; P<0.05). Sponge extracts 
demonstrated a varied degree of cell protection from the toxicity induced by Aβ1-42 
(Figure 5). 76% of the sponge extracts (13) showed neuroprotection at the highest 
concentration (25 µg/ml). More than half of the green algal and brown algal extracts 
significantly reduced the toxicity of Aβ1-42 (Figure 6 and Figure 7), while only half of 
the red algae extracts showed neuroprotective activity (Figure 8). Interestingly, five 
extracts (D8, D16, D19, D21, and D40) from marine sponges showed neuroprotective 
activities in both tested concentrations, while ten extracts from algae [2 from green 
algae (C9 and C10), 4 from brown algae (P2, P3, P9, and P10), and 4 from red algae 
(R1, R3, R4, and R11)] were active in protecting the cells from the toxicity of Aβ in 
both tested concentrations. Based on the taxonomic distribution of sponges’ species, 
extracts from all nontoxic species of Dendroceratida, Dictyoceratida, and 
Haplosclerida orders were neuroprotective to cells against the toxicity induced by of 
Aβ1-42. Three species of the Haplosclerida order were active in both concentrations, 
which highlighted the potential of these orders for providing neuroprotective 
compounds. In green algae, extracts from half of nontoxic species of Codiaceae 
family showed significant neuroprotective activity. In brown algae, both extracts from 
Dictyopteris genus showed significant neuroprotective activities in both tested 
concentrations. 80% of nontoxic extracts from Fucales order were shown to protect 
PC-12 cells against Aβ1-42, while all extracts from Sporochnales order failed to 
provide any protection. In red algae, 75% of nontoxic extracts from Ceramiales order 
showed neuroprotective activities, while extracts from half of species from 
Corallinales order were neuroprotective.  Gigartinales order did not provide any 














To confirm the significant effects of these active extracts, Bonferroni correction was 
used and only seven extracts (D8 and D40 from sponges; C10 from green algae; and 
P1, P9, P10, and P14 from brown algae) demonstrated significant neuroprotective 
activities.  These extracts are the priorities for further studies in identifying active 
compounds.  
 
Figure 5: Neuroprotection activity of sponge extracts against Aβ1-42 induced 
cytotoxicity in PC-12 cells using MTT assay showing relative cell viability (%). 
Each value is the mean ± SEM of three independent experiments (* p <0.05, ** p 

















































































Figure 6: Neuroprotection activity of green algae extracts against Aβ1-42 induced 
cytotoxicity in PC-12 cells using MTT assay showing relative cell viability (%). 
Each value is the mean ± SEM of three independent experiments (* p <0.05, ** p 
<0.01, and ***p <0.005 versus control Aβ) 
 
 
Figure 7: Neuroprotection activity of brown algae extracts against Aβ1-42 induced 
cytotoxicity in PC-12 cells using MTT assay showing relative cell viability (%). 
Each value is the mean ± SEM of three independent experiments (* p <0.05, ** p 
<0.01, and ***p <0.005 versus control Aβ) 
 
 
Figure 8: Neuroprotection activity of red algae extracts against Aβ1-42 induced 
cytotoxicity in PC-12 cells using MTT assay showing relative cell viability (%). 
Each value is the mean ± SEM of three independent experiments (* p <0.05, ** p 















































































3.3 Validation of cytotoxicity of selected extracts by LDH assay 
To validate the cytotoxicity of extracts identified by MTT assay based on 
mitochondrial metabolic activity, a second assay-LDH assay was conducted to test 
five selected extracts (at 25 µg/mL) with the most significant neuroprotective 
activities. All the five selected extracts showed less than 10% of cytotoxicity as 




Figure 9: Relative cell viability (%) of PC12 cells estimated by LDH assay 
following 48 h treatment with selected extracts at 25 µg/mL. Each value is the 




60% of the marine sponge extracts tested (26 out of 43 extracts) at a concentration 
range of 0.25-25µg/ml were cytotoxic to PC-12 cells. Cytotoxic compounds in 
sponges are common given that half of the anticancer compounds discovered during 
2001 to 2010 were isolated from sponges (Mehbub et al., 2014).   In addition, a study 
showed that four dictyodendrins isolated from Ianthella sp. were shown to be active 



































(BACE); however three of them were cytotoxic to SW620 cells (Zhang et al., 2012b). 
Three extracts (D17, D18, and D22) belonging to the Haplosclerida order showed the 
highest cytotoxicity, with cell viability less than 40%. 
It is significant though that 76% (13 out of 17) of those non-toxic sponge extracts 
demonstrated promising neuroprotective activity, by reducing the cytotoxicity 
induced by Aβ.  
 
For all the three algae classes combined, 43% of the algae extracts (21 out of 49 algae 
extracts) were shown to reduce cell viability to less than 90%. The algae extracts are 
less toxic when compared with the sponge extracts. Among these three algae classes, 
brown algae extracts showed the least toxic, with only 31%, when compared with 46% 
for green algae and 50% for red algae.   
 
In contrast to the cytotoxicity trend, the highest percentage (44%) of brown algae 
extracts demonstrated neuroprotective activity against Aβ-induced cytotoxicity to PC-
12 cells, followed by 31% green algae and 25% red algae.  
 
MTT assay is based on the measurement of mitochondria metabolic activity 
(Mosmann, 1983), and a second assay is preferred to validate the cytotoxicity. LDH 
assay based on detecting lactate dehydrogenase released into media (Korzeniewski 
and Callewaert, 1983) was therefore used on five randomly selected five active 
extracts. The results from two assays are very similar and comparable, which 
demonstrated the reliability of the screening tests. 
 
Based on the location sites, extracts with demonstrated neuroprotective activities were 














neuroprotective extracts, which was American River with three sponge extracts (D2, 
D11, and D35) and Marion Reef with 1 sponge and 2 macroalgae extracts (D19, P2, 
R4). In addition, six locations which include Point Ellen (D10 and D20), Margrete 
Brock (D16, C10), West of Cape (D30 and D43), Godfrey Island (D40 and P5), 
Horseshoe Reef-0.65 miles (C11 and R1), and Pandalowie Bay (P6 and R7) showed 
to have 2 extracts with neuroprotective activities. This highlights the diverse activities 
among different location sites.  
 
Based on sponge taxonomy, all of the orders in this study with the exception 
Biemnida order have been reported before to have compounds with neuroprotective 
activities. In addition, 7 families (Dysideidae, Irciniidae, Thorectidae, Niphatidae, 
Desmacididae, Halichondriidae, and Aplysinidae) have been reported before to have 
neuroprotective compounds (Alghazwi et al., 2016a).  
 
Table 6: Summary of sponge, green algae, brown algae, and red algae showing 
cytotoxicity and neuroprotective activity against PC-12 cells 





extracts by one way 
ANOVA 
Total neuroprotective 
extracts by Bonferroni 
correction 
Sponge 43 26 (60%) 13 (30%) 2 (4.7%) 
Green algae 13 6 (46%) 4 (30.7%) 1 (7.7%) 
Brown algae 16 5 (31.25%) 7 (43.75%) 4 (25%) 
Red algae 20 10 (50%) 5 (25%) 0 (0%) 
Total 92 47 (51.1%) 29 (31.5%) 7 (7.6%) 
 
Even though many sponges and macroalgae extracts were reported to show 
neuroprotective activity previously from similar families to the one used in our 














activity for the first time. From sponge samples, only four of these extracts were 
reported previously from a similar family, and nine of these extracts were reported for 
the first time. Interestingly, all of the green algae extracts were reported before by 
other researchers from a similar family to show neuroprotective activity. In red algae, 
2 families were reported previously, and 3 families were yet to be reported (Table 7). 
All brown algal extracts are reported here to show neuroprotective activity for the first 
time. This highlights the diverse species in South Australia, and also their great 
potential for neuroprotective drug discovery, as all the species are reported for the 
first time. 
In contrast, lack of neuroprotective activity or cytotoxicity was presented in some 
extracts from similar family or genus to the reported neuroprotective compounds in 
the literature. This include Cribrochalina genus, as extract D23 was toxic and 
excluded from further studies. Two compounds, namely cribronic acid (2S,4R,5R)-5-
hydroxy-4- sulfooxypiperidine-2-carboxylic acid and (2S,4S)-4-sulfooxypiperidine-2-
carboxylic acid, isolated from Cribrochalina olemda have reported to have glutamate 
receptor inhibition activity (Sakai et al., 2003). Hymenialdisine isolated from 
Halichondriidae demonstrated kinase inhibition by reducing the activity of GSK- 3β 
and CK1 (Meijer et al., 2000). However, in our screening, extract D14 isolated from 
Halichondriidae was toxic, with observed cell viability of less than 80%. Three 
compounds; spiralisone A, spiralisone B and chromone 6 were isolated from Zonaria 
spiralis and found to inhibit kinase activity (Zhang et al., 2012d). Extract P3 is from 
the same genus Zonaria and was found to be toxic to PC-12 cells. Many compounds 
isolated from Sargassum genus demonstrated neuroprotective activities. Compounds 
such as (5E,10Z)-6,10,14-Trimethylpentadeca-5,10-dien-2,12-dione and (5E,9E,13E)-














cholinesterase activity (Ryu et al., 2003). Fucoxanthin demonstrated DPPH radical-
scavenging activity (Yan et al., 1999) and inhibited cell toxicity induced by hydrogen 
peroxide (Heo et al., 2008). Three plastoquinone and nineteen meroditerpenoid 
compounds demonstrated antioxidant activity by reducing lipid peroxidation and 
radical scavenging against DPPH (Mori et al., 2005), (Jung et al., 2008). Alginic acid 
has shown anti-inflammatory activity (Sarithakumari and Kurup, 2013) and four 
compounds; MC14 (Tsang et al., 2001), sargaquinoic acid (Kamei and Tsang, 2003), 
sargachromenol (Tsang et al., 2005) and pheophytin A (Ina et al., 2007) have shown 
enhanced neuronal growth. Only one extract, P11 of Sargassum genus tested in our 
study reduced cell viability to less than 90%.  
 
The most promising orders from sponge taxonomy are the Haplosclerida order, as 
both provided three neuroprotective extracts at both tested concentrations. Moreover, 
the Dictyoceratida order provided four neuroprotective extracts. From green algae, 
Codium genus seems to be promising as it provides three neuroprotective extracts. 
From brown algae, two neuroprotective extracts were isolated from Dictyopteris 
genus and three others from the Sargassaceae family. The Ceramiales order provided 
three neuroprotective extracts, while Corallinaceae family provided two in the red 
algae. For that reason, more research should be conducted in these families and orders 



















Table 7: Summary of reported compounds/extracts from sponge, green algae, brown 
algae, and red algae from similar family or genus in this study with their reported 
activities 




Reported activity Reference 












kainic acid (KA) receptor and 
[3H]α-amino-3-hydroxy-5-
methyl-4- isoxazolepropionic 
acid (AMPA) receptor 
inhibitors 




acid-type (NMDA) and KA 
receptors 
Reduce reactive oxygen species 
(ROS) formation 





(Sakai et al., 
2001a) 
 
(Sakai et al., 
2004) 
 
(Suna et al., 
2009) 
Ircinia genus D8 Methanol extracts from 
Ircinia spinulosa and Ircinia 
fasciculate 




















Aplysina genus D40 NP04634 from Aplysina 
cavernicola 
Reduce to toxicity in bovine 
adrenal medullary chromaffin 
induced by calcium 



































(Liu et al., 
2013) 
 






(de Souza et 
al., 2009) 
Codium genus C9, C10, 
and C11 
Clerosterol isolated from 
Codium fragile 

















Reduce oxidative stress (Li et al., 
2012) 
 
The extracts that have shown positive results by inhibiting Aβ toxicity in PC-12 cells 
are likely to work via different and possibly multiple mechanisms. These mechanisms 














activity. For instance, these extracts might be able to inhibit BACE which is an 
important enzyme in the aberrant production of Aβ from amyloid precursor protein 
(APP). Another possible mechanism is that the extracts are able to reduce reactive 
oxygen species (ROS) which occurs as a consequence of Aβ exposure (Butterfield 
and Boyd‐Kimball, 2004). For example, pinostrobin was found to inhibit the toxicity 
of Aβ via inhibiting intracellular ROS (Xian et al., 2012). Aβ can induce apoptosis as 
well, so these extracts might inhibit caspase 3 and 9, or inhibit Bcl and Bax. 
Previously, astaxanthin has been found to inhibit Aβ toxicity via the apoptosis 
pathway, inhibiting Bax and upregulating Bcl-2, while also upregulating HO-1 
expression (Wang et al., 2010).  
Further studies are required to isolate and purify the active compounds from these 
active extracts identified. Novel compounds are expected to be discovered by further 
mechanistic insight into cellular pathways for neuroprotection. 
5- Conclusion 
This study has demonstrated that marine sponges and macroalgae collected in South 
Australia are a potential source of neuroprotective compounds, with one-third of 92 
extracts screened (29 extracts) found to reduce neurotoxicity induced by Aβ in PC-12 
cells. More than half of these extracts (15 extracts out of 29 extracts) were active in 
both tested concentrations. 65% of these sponge and macroalgae extracts from genus 
that have not been reported before, to demonstrate protection against Aβ-
neurotoxicity. These results are of significance for further studies isolating and 
characterizing the active compounds from these extracts and understand their 
mechanisms of actions for potential neuroprotective drug discovery and development.  
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 60% of South Australian marine sponge extracts demonstrated cytotoxicity  
 Brown algae demonstrated the least cytotoxicity among other algae classes 
 About 31.5% of extract demonstrated neuroprotective activities  
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